Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYJAAD case reports

Bimekizumab for Darier disease: A case report highlighting dual IL-17A and IL-17F inhibition as a potential treatment.

  • Weipeng Xie1
  • Priya Agarwal2
  • Medha Rao2
  • Lisa Zhou2
  1. 1NYU Grossman School of Medicine, New York, New York.
  2. 2Department of Dermatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Read full textPDFDOICite

Related

  1. Phenotypic shift from active class IV lupus nephritis to lupus podocytopathy: a case report highlighting the treatment-altering role of repeat kidney biopsy
    Zhifa Wang, Jinxiu Deng, Jinfeng Shen +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  2. Molecular mechanisms of AcrVA-mediated Cas12a inhibition and their potential applications
    Yong Jun Kang, Hyun Ho Park
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0MicrobiologyFrontiersCrossref
  3. Pharmacological BET Protein Inhibition Reverts Niemann-Pick Type C Disease-Associated Changes in Human iPSC-Derived Cortical Neurons
    F. Benigni, M. Parente, C. Marioli +8
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  4. Photobiomodulation as potential novel third line tool for non-invasive treatment of hidradenitis suppurativa
    Paola Tricarico, Luisa Zupin, Giulia Ottaviani +6
    Giornale italiano di dermatologia e venereologiaPeer-reviewedLicence not stated10 citedGeneral biologyHAL
  5. Biophysical modeling of excitation/inhibition imbalance in Alzheimer's disease
    Q. Deng, C. Chen, B. Zikopoulos +1
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv

Cite

BibTeXRIS
BibTeX
@article{xie2026bimekizumab,
  title = {{Bimekizumab for Darier disease: A case report highlighting dual IL-17A and IL-17F inhibition as a potential treatment.}},
  author = {Weipeng Xie and Priya Agarwal and Medha Rao and Lisa Zhou},
  journal = {JAAD case reports},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jdcr.2026.08.054},
  url = {https://europepmc.org/article/MED/42904207},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Bimekizumab for Darier disease: A case report highlighting dual IL-17A and IL-17F inhibition as a potential treatment.
AU  - Weipeng Xie
AU  - Priya Agarwal
AU  - Medha Rao
AU  - Lisa Zhou
PY  - 2026
DA  - 2026/09/08
JO  - JAAD case reports
DO  - 10.1016/j.jdcr.2026.08.054
UR  - https://europepmc.org/article/MED/42904207
SN  - 2352-5126
ER  -